Literature DB >> 2894877

Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.

W Martin1, D G White, A H Henderson.   

Abstract

1. Two directly-acting stimulants of soluble guanylate cyclase, glyceryl trinitrate (0.1 microM) and sodium azide (10 microM), and a receptor-mediated stimulant of particulate guanylate cyclase, atriopeptin II (10 nM), each elevated the cyclic GMP content of primary cultures of pig aortic endothelial cells without affecting the cyclic AMP content. 2. Two receptor-mediated stimulants of adenylate cyclase, glucagon (1 microM) and isoprenaline (10 microM), had no effect on the cyclic AMP or cyclic GMP content of these cells, but the directly acting stimulant, forskolin (30 microM), induced a small increase in cyclic AMP content. 3. Three agents that release endothelium-derived relaxing factor (EDRF); bradykinin (0.1 microM), ATP (10 microM) and ionophore A23187 (0.1 microM), each markedly elevated the cyclic GMP content of pig aortic endothelial cells, but acetylcholine (1 microM) had no effect. None of these agents had any effect on cyclic AMP content. 4. Two agents that potentiate the actions of EDRF; M & B 22948 (100 microM) and superoxide dismutase (30 units ml-1), each elevated the cyclic GMP content of pig aortic endothelial cells without affecting the cyclic AMP content. Pretreating cells with catalase (100 units ml-1) did not affect the rise in cyclic GMP content induced by superoxide dismutase (30 units ml-1). 5. Pretreatment of pig aortic endothelial cells with haemoglobin (10 microM) reduced the resting content of cyclic GMP and blocked the increase in cyclic GMP content induced by glyceryl trinitrate (0.1 microM), sodium azide (10 microM), bradykinin (0.1 microM), ATP (10 microM), ionophore A23187 (0.1 microM), M & B 22948 (100 microM) and superoxide dismutase (30 units ml-1), but not that induced by atriopeptin II (10 nM). 6. Pretreatment of pig aortic endothelial cells with an inhibitor of soluble guanylate cyclase, methylene blue (20 microM), had no effect on the resting content of cyclic GMP. Methylene blue (20 microM) blocked the increase in cyclic GMP content induced by glyceryl trinitrate (0.1 microM), M & B22948 (100 microM) and bradykinin (0.1 microM), but not that induced by atriopeptin II (10 nM). 7. The data show that soluble guanylate cyclase, particulate guanylate cyclase and adenylate cyclase are present in pig aortic endothelial cells. They further suggest that EDRF, produced spontaneously or in response to vasoactive agents, elevates endothelial cyclic GMP content by stimulating soluble guanylate cyclase. It is possible that this may serve as a feedback loop by which the endothelial cell modulates EDRF production.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894877      PMCID: PMC1853777          DOI: 10.1111/j.1476-5381.1988.tb11426.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  48 in total

1.  The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system.

Authors:  J M KISSANE; E ROBINS
Journal:  J Biol Chem       Date:  1958-07       Impact factor: 5.157

2.  Hormone and neurotransmitter receptors in an established vascular endothelial cell line.

Authors:  V Buonassisi; J C Venter
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

3.  Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation.

Authors:  P A Craven; F R DeRubertis
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

4.  Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine.

Authors:  M Field; L H Graf; W J Laird; P L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

Review 5.  Properties and regulation of guanylate cyclase and some proposed functions for cyclic GMP.

Authors:  F Murad; W P Arnold; C K Mittal; J M Braughler
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

6.  Prostacyclin stimulation of dog arterial cyclic AMP levels.

Authors:  O V Miller; J W Aiken; D P Hemker; R J Shebuski; R R Gorman
Journal:  Prostaglandins       Date:  1979-12

7.  PGI2 enhanced cAMP content in bovine coronary arteries in the presence of isobutylmethylxanthine.

Authors:  A Dembinska-Kiec; W Rücker; P S Schönhöfer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

8.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

9.  Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin.

Authors:  N K Hopkins; R R Gorman
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

10.  Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium.

Authors:  S Moncada; A G Herman; E A Higgs; J R Vane
Journal:  Thromb Res       Date:  1977-09       Impact factor: 3.944

View more
  29 in total

1.  Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.

Authors:  R J Gryglewski; A Zembowicz; D Salvemini; G W Taylor; J R Vane
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Effects of cyclic nucleotides and phorbol myristate acetate on proliferation of pig aortic endothelial cells.

Authors:  S A Moodie; W Martin
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

3.  Inhibition of inositol 1,4,5-trisphosphate formation by cyclic GMP in cultured aortic endothelial cells of the pig.

Authors:  D Lang; M J Lewis
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

4.  Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells.

Authors:  J M Richards; I F Gibson; W Martin
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

5.  Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide.

Authors:  D Salvemini; R Korbut; E Anggård; J Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

6.  Modulation of agonist-induced calcium mobilisation in bovine aortic endothelial cells by phorbol myristate acetate and cyclic AMP but not cyclic GMP.

Authors:  K W Buchan; W Martin
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

7.  Modulation of arterial endothelial permeability: studies on an in vitro model.

Authors:  J R Gudgeon; W Martin
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

8.  Prostacyclin-dependent cyclic AMP formation in endothelial cells.

Authors:  H Schröder; K Schrör
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

9.  The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture.

Authors:  D G White; J W Mundin; M J Sumner; I S Watts
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

10.  Modulation of barrier function of bovine aortic and pulmonary artery endothelial cells: dissociation from cytosolic calcium content.

Authors:  K W Buchan; W Martin
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.